1. Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
GlobalData, the industry analysis specialist, has released its new report, “Traumatic Brain
Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an
essential source of information and analysis on the global Traumatic Brain Injury
Therapeutics market. The report identifies the key trends shaping and driving the global
Traumatic Brain Injury Therapeutics market. The report also provides insights on the
prevalent competitive landscape and the emerging players expected to significantly alter
the market positioning of the current market leaders. Most importantly, the report
provides valuable insights on the pipeline products within the global Traumatic Brain
Injury Therapeutics sector. This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house analysis by
GlobalData’s team of industry experts
Scope
The report provides information on the key drivers and challenges of the Traumatic Brain
Injury Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan)
Traumatic Brain Injury Therapeutics market revenues data from 2006 to 2011, forecast for
eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action
being developed and emerging trends by seven key markets. Pipeline candidates fall under
major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Traumatic Brain
Injury Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization,
unmet needs and the implications for the Traumatic Brain Injury Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Traumatic Brain Injury
Therapeutics market
Get more information of this report @ http://www.reportsnreports.com/reports/167922-traumatic-
brain-injury-therapeutics-pipeline-assessment-and-market-forecasts-to-2019.html
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products
and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Traumatic
Brain Injury Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market
segments and companies likely to impact the global Traumatic Brain Injury Therapeutics market in
future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by

2. analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-
strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that
present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Traumatic Brain Injury Therapeutics market landscape? –
Identify, understand and capitalize.
Report Details:
Published: June 2012
No. of Pages: 98
Price: Single User License: US $ 3995 Corporate User License: US $ 11985
Major points covered in Table of Contents of this report include:
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7
2 Traumatic Brain Injury Therapeutics - Introduction 8
2.1 Disease Overview 8
2.1.1 Classification of Traumatic Brain Injury 9
2.1.2 Types of Traumatic Brain Injury 11
2.1.3 Effects of Traumatic Brain Injury 12
2.1.4 Post-Injury Complications Associated with Traumatic Brain Injury 13
2.2 Epidemiology 14
2.2.1 Traumatic Brain Injury: “A Silent Epidemic” in the US 16
2.2.2 The UK 17
2.2.3 Spain 17
2.2.4 France 17
2.2.5 Italy 17
2.2.6 Germany 17
2.2.7 Japan 17
2.2.8 Mortality 18
2.2.9 Quality of Life Parameters 19
2.2.10 Pharmacoeconomic Burden 19
2.3 Etiology 19
2.4 Pathophysiology 21
2.4.1 Primary Injury 21
2.4.2 Secondary Injury 22
2.4.3 Inflammatory Response 23
2.4.4 Repair-Regeneration 23
2.5 Signs and Symptoms 23
2.6 Diagnosis 24
2.6.1 Initial Measures 24

3. 2.6.2 Complete Clinical Evaluation 25
2.7 Treatment and Management Pattern 28
2.7.1 Acute Management of Traumatic Brain Injury in Hospital 28
2.7.2 Treatment of Mild Traumatic Brain Injury 33
2.7.3 Treatment of Post-Traumatic Brain Injury Complications 36
2.7.4 Rehabilitation 39
2.8 Referral Pathway 39
2.9 GlobalData Pipeline Report Guidance 41
3 Traumatic Brain Injury Therapeuctics - Market Characterization 42
3.1 Overview 42
3.2 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Global 43
3.3 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Global 44
3.4 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury – Global 45
3.5 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – The US 46
3.6 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – The US 47
3.7 Traumatic Brain Injury Therapeutics Market Distribution based on Severity of Injury – The US 48
3.8 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – France 49
3.9 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – France 50
3.10 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, France 51
3.11 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Germany 52
3.12 Traumatic Brain Injury Therapeutics Market Forecast (2011-2019) – Germany 53
3.13 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Germany 54
3.14 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Italy 55
3.15 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Italy 56
3.16 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Italy 57
3.17 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Spain 58
3.18 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Spain 59
3.19 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Spain 60
3.20 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – The UK 61
3.21 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – The UK 62
3.22 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, The UK 63
3.23 Traumatic Brain Injury Therapeutics Market Size (2006–2011) – Japan 64
3.24 Traumatic Brain Injury Therapeutics Market Forecast (2011–2019) – Japan 65
3.25 Traumatic Brain Injury Therapeutics Market Distribution based upon Severity of Injury, Japan 66
3.26 Drivers and Barriers for Traumatic Brain Injury Therapeutics Market 67
3.26.1 Drivers for Traumatic Brain Injury Therapeutics Market 67
3.26.2 Barriers for TBI Therapeutics Market 67
3.27 Opportunity and Unmet Need Analysis 69
3.27.1 Opportunity and Unmet Need in Traumatic Brain Injury Therapeutics Market 69
3.28 Key Takeaway 69
4 Traumatic Brain Injury Therapeutics - Competitive Assessment 70
4.1 Overview 70
4.2 Strategic Competitor Assessment 70
4.3 Product Profile for the Major Product in the Traumatic Brain Injury Therapeutics 70
4.3.1 Mannitol 70
4.4 Key Takeaway 71
5 Traumatic Brain Injury Therapeutics - Pipeline Assessment 72
5.1 Overview 72

4. 5.2 Strategic Pipeline Assessment 72
5.3 Traumatic Brain Injury Therapeutics Pipeline – Pipeline by Phases of Development 73
5.3.1 Traumatic Brain Injury Therapeutics – Phase III Pipeline 73
5.3.2 Traumatic Brain Injury Therapeutics –Phase II Pipeline 73
5.3.3 Traumatic Brain Injury Therapeutics – Phase I/II Pipeline 74
5.3.4 Traumatic Brain Injury Therapeutics –Phase I Pipeline 74
5.3.5 Traumatic Brain Injury Therapeutics – IND Filed 74
5.3.6 Traumatic Brain Injury Therapeutics – Preclinical Phase 75
5.3.7 Traumatic Brain Injury Therapeutics – Discovery Pipeline 75
5.4 Technology Trends Analytic Framework 76
5.5 Traumatic Brain Injury Therapeutics Market –Pipeline by Mechanism of Action 78
5.6 Molecule Profiling for Promising Drug under Clinical development 79
5.6.1 BHR-100 79
5.7 Key Takeaway 80
6 Traumatic Brain Injury Therapeutics - Clinical Trials Mapping 81
6.1 Clinical Trials by Region/ Country 81
6.2 Clinical Trials by Phase 82
6.3 Clinical Trials by Trial Status 83
6.4 Top 10 companies participating in Therapeutics Clinical Trials 84
6.5 Prominent Sponsors 85
7 Traumatic Brain Injury Therapeutics - Strategic Assessment 87
7.1 Key Events Impacting the Future Traumatic Brain Injury Market 87
7.2 Implications for Future Traumatic Brain Injury Market Competition 88
8 Traumatic Brain Injury Therapeutics - Future Players 89
8.1 Introduction 89
8.2 Company Profiles 89
8.2.1 BHR Pharma, LLC 89
9 Traumatic Brain Injury Therapeutics - Appendix 90
9.1 Market Definitions 90
9.2 Abbreviations 90
9.3 Bibliography 91
9.4 Research Methodology 93
9.4.1 Coverage 93
9.4.2 Secondary Research 94
9.4.3 Primary Research 94
9.4.4 Modelling and Forecasting 94
9.4.5 Expert Panel Validation 97
9.5 Contact Us 97
9.6 Disclaimer 98
Related Reports @ http://www.reportsnreports.com/publisher/globaldata/
Contact:
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441

5. sales@reportsandreports.com
Connect With Us: